Failed back surgery syndrome affects a meaningful portion of spine surgery patients — and for many, it may be preventable. Regenerative disc repair, including intra-annular fibrin injection, may offer a viable path before surgery is scheduled. Candidates are evaluated individually to determine whether biologic options are appropriate for their condition.

1. Failed Back Surgery Syndrome Is a Recognized Clinical Pattern — Not a Rare Exception

Many patients are surprised to learn that persistent or worsening pain after spine surgery has its own clinical name: failed back surgery syndrome (FBSS). FBSS is not an uncommon outcome — it is a recognized pattern in which surgery does not resolve the underlying source of discogenic or radicular pain.

Common contributing factors include:

• Operating on a disc that was not the actual pain generator
• Scar tissue formation around nerve roots following the procedure
• Adjacent segment disease developing after spinal fusion
• Recurring disc herniation at the same or a neighboring level

Understanding this risk is one reason our clinical team evaluates candidates carefully before recommending any treatment path — surgical or otherwise. For patients who have already experienced a surgical outcome that did not meet expectations, regenerative options may still be worth exploring.

2. Annular Tears Are a Frequent Source of Chronic Pain That Surgery Often Does Not Address

A significant proportion of patients with chronic low back pain have annular tears — small fissures in the outer wall of the intervertebral disc. These tears can generate significant, ongoing pain, but they are not always visible on standard MRI sequences and are frequently undertreated or misattributed to other causes.

When an annular tear is the primary pain source, traditional surgery may not address it effectively. Intra-annular fibrin injection targets the tear site directly, introducing a biologic material designed to support the disc’s natural repair environment. Many patients with confirmed annular tears have experienced meaningful improvement through this approach, though individual outcomes vary and candidacy depends on each patient’s diagnostic picture.

Learn more about how our team approaches non-surgical annular tear repair and what the evaluation process involves.

3. Identifying the Correct Pain Source Before Any Treatment Is the Most Critical Step

One of the most preventable contributors to failed back surgery is proceeding with an operation before the actual pain generator has been confirmed. Pain location, imaging findings, and symptom history each provide useful information — but none alone is sufficient to guide treatment selection.

Our clinical team uses a structured evaluation process that may include:

• Advanced MRI review, including assessment for annular disruption and internal disc derangement
• Provocative discography when appropriate to confirm the pain-generating disc
• Functional assessment of pain behavior and prior treatment response
• A thorough review of prior surgical, injection, and conservative care history

Patients who have been told surgery is their only option may benefit from a second diagnostic evaluation. A different clinical lens sometimes reveals treatment pathways that were not previously identified. Our team recommends reviewing these five signs that a second opinion before spinal fusion may be warranted before making a final decision.

4. Biologic Disc Repair Typically Involves Less Structural Disruption Than Surgery

Spinal fusion and discectomy are major procedures. They involve anesthesia, tissue disruption, hardware implantation in many fusion cases, and recovery timelines that may extend for months. Even when surgery is successful, the altered biomechanics of the fused spine may accelerate degeneration at adjacent levels over time — a condition known as adjacent segment disease.

Biologic disc repair approaches, including intra-annular fibrin injection, are performed under fluoroscopic guidance without the structural alterations associated with surgery. No bone is removed, no hardware is implanted, and adjacent spinal segments are not mechanically affected by the treatment. This structural preservation may be particularly meaningful for patients in physically demanding occupations or those who want to preserve future treatment options.

Results vary by individual, and biologic disc repair is not appropriate for every presentation. However, many patients and their care teams appreciate that this approach does not foreclose surgical options if those become necessary later. Explore how biologic disc repair compares to spinal fusion across key clinical dimensions.

Expert Take

From our clinical team’s perspective, the most avoidable cases of failed back surgery are those where surgery was recommended before conservative and biologic options were fully explored. The diagnostic process matters as much as the treatment itself — accurately identifying the pain generator is the starting point for any meaningful recovery plan. Biologic disc repair is not appropriate for every presentation, but for many candidates, it deserves serious consideration before a surgical commitment is made. Patients who ask about regenerative options early in their care journey tend to have more pathways available to them.

5. A Second Opinion Before Surgery Can Change the Entire Trajectory of Your Care

In many spine cases, the difference between a surgical recommendation and a regenerative candidacy evaluation is simply a matter of who a patient sees first. Spine surgeons are trained to evaluate surgical solutions; clinicians who specialize in biologic disc repair evaluate whether non-surgical approaches may achieve comparable goals with less structural commitment.

This does not mean surgery is wrong — there are presentations where surgical intervention remains the most clinically appropriate path. Severe spinal instability, progressive neurological deficits, and certain structural failures may require operative management. But for patients with discogenic pain, annular tears, or early degenerative disc disease who have not yet exhausted biologic options, a second opinion may reveal that surgery is not yet necessary.

Patients who have already received a fusion recommendation may find it useful to review this guide to spinal fusion alternatives before finalizing a treatment plan. Understanding the full range of available approaches allows for a more informed conversation with your care team about which path fits your specific condition and goals.

How Our Team Evaluates Candidates for Regenerative Disc Repair

Candidacy for intra-annular fibrin injection or other biologic disc repair approaches depends on the specific nature of your disc condition, your diagnostic findings, and your prior treatment history. Our clinical team evaluates each case individually — there is no standardized checklist that applies uniformly across patients.

If you are weighing a surgical recommendation, have been told conservative care has failed, or have already experienced a surgical outcome that did not resolve your pain, a candidacy evaluation may clarify whether regenerative disc repair belongs in your care plan. For many patients, biologic options represent a meaningful step that is worth exploring before more permanent structural changes are made.

Contact Valor Spine to request an evaluation and find out whether fibrin disc treatment may be appropriate for your condition.